<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><title>Assign ESMO 2020 — assign_esmo2020 • EndoTools</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link href="https://cdnjs.cloudflare.com/ajax/libs/bootswatch/3.4.0/cerulean/bootstrap.min.css" rel="stylesheet" crossorigin="anonymous"><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Assign ESMO 2020 — assign_esmo2020"><meta property="og:description" content="Assign ESMO 2020 based on stage, grade, histological subtype group,
myometrial invasion, and LVSI. Molecular classification and residual disease
can be used if available."><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--></head><body data-spy="scroll" data-target="#toc">
    

    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">EndoTools</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.3.7</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../reference/index.html">Reference</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
  <a href="https://github.com/TalhoukLab/EndoTools" class="external-link">
    <span class="fa fa-github"></span>
     
  </a>
</li>
      </ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Assign ESMO 2020</h1>
    
    <div class="hidden name"><code>assign_esmo2020.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Assign ESMO 2020 based on stage, grade, histological subtype group,
myometrial invasion, and LVSI. Molecular classification and residual disease
can be used if available.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="fu">assign_esmo2020</span><span class="op">(</span>
  <span class="va">stage_full</span>,
  <span class="va">grade</span>,
  <span class="va">hist_gr</span>,
  <span class="va">myo</span>,
  <span class="va">lvi</span>,
  eclass <span class="op">=</span> <span class="cn">NULL</span>,
  residual <span class="op">=</span> <span class="cn">NULL</span>
<span class="op">)</span></code></pre></div>
    </div>

    <div id="arguments">
    <h2>Arguments</h2>
    <dl><dt>stage_full</dt>
<dd><p>FIGO stage: I, II, III, IV with substages</p></dd>
<dt>grade</dt>
<dd><p>tumour grade: 1, 2, 3</p></dd>
<dt>hist_gr</dt>
<dd><p>histological subtype group: endometrioid or non-endometrioid</p></dd>
<dt>myo</dt>
<dd><p>myometrial invasion: none, 1-50%, &gt;50%</p></dd>
<dt>lvi</dt>
<dd><p>lymphovascular space invasion: negative, positive, focal, extensive</p></dd>
<dt>eclass</dt>
<dd><p>molecular classification: "MMRd", "POLEmut", "p53abn", or
"NSMP/p53wt"</p></dd>
<dt>residual</dt>
<dd><p>residual disease: "&lt;1cm", "&gt;=1cm", "microscopic", or "no
residual". Use if available. Microscopic residual is regarded as no
residual disease.</p></dd>
</dl></div>
    <div id="value">
    <h2>Value</h2>
    <p>ESMO 2020 assigned into "low", "intermediate", "high-intermediate",
"high", "advanced", or "metastatic". Unassignable cases are <code>NA</code>.</p>
    </div>
    <div id="details">
    <h2>Details</h2>
    <p>ESMO 2020 is assigned using stage, grade, histological subtype group,
myometrial invasion, and LVSI into low, intermediate, high-intermediate,
high, advanced, and metastatic risk based on the following criteria with and
without molecular classification/residual disease:</p>
<p><strong>With molecular classification</strong></p><ul><li><p>low:</p><ul><li><p>stage I-II, POLEmut, (no residual disease if known)</p><ul><li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IA, grade 1/2, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
</ul></li>
<li><p>intermediate:</p><ul><li><p>stage IB, grade 1/2, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
<li><p>stage IA, grade 3, endometrioid, LVSI negative or focal, MMRd/NSMP</p></li>
<li><p>stage IA, no myometrial invasion, p53abn</p></li>
</ul></li>
<li><p>high-intermediate:</p><ul><li><p>stage IA/IB, endometrioid, LVSI positive or extensive, MMRd/NSMP</p></li>
<li><p>stage IB, grade 3, endometrioid, MMRd/NSMP</p></li>
<li><p>stage II/IIA, endometrioid, MMRd/NSMP</p></li>
</ul></li>
<li><p>high:</p><ul><li><p>stage III-IVA, endometrioid, MMRd/NSMP, (no residual disease if known)</p></li>
<li><p>stage I-IVA, &gt;0% myometrial invasion, p53abn, (no residual disease if known)</p><ul><li><p>for stage I-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IA, non-endometrioid or mixed subtype, &gt;0% myometrial invasion, MMRd/NSMP, (no residual disease if known)</p><ul><li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IB-IVA, non-endometrioid or mixed subtype, MMRd/NSMP, (no residual disease if known)</p><ul><li><p>for stage IB-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
</ul></li>
<li><p>advanced:</p><ul><li><p>stage III-IVA, any molecular type, (with residual disease if known)</p></li>
</ul></li>
<li><p>metastatic:</p><ul><li><p>stage IVB, any molecular type</p></li>
</ul></li>
</ul><p><strong>Without molecular classification</strong></p><ul><li><p>low:</p><ul><li><p>stage IA, grade 1/2, endometrioid, LVSI negative or focal</p></li>
</ul></li>
<li><p>intermediate:</p><ul><li><p>stage IB, grade 1/2, endometrioid, LVSI negative or focal</p></li>
<li><p>stage IA, grade 3, endometrioid, LVSI negative or focal</p></li>
<li><p>stage IA, no myometrial invasion</p></li>
</ul></li>
<li><p>high-intermediate:</p><ul><li><p>stage IA/IB, endometrioid, LVSI positive or extensive</p></li>
<li><p>stage IB, grade 3, endometrioid</p></li>
<li><p>stage II/IIA, endometrioid</p></li>
</ul></li>
<li><p>high:</p><ul><li><p>stage III-IVA, endometrioid, (no residual disease if known)</p></li>
<li><p>stage IA, non-endometrioid or mixed subtype, &gt;0% myometrial invasion, (no residual disease if known)</p><ul><li><p>missing residual disease is regarded as no residual disease</p></li>
</ul></li>
<li><p>stage IB-IVA, non-endometrioid or mixed subtype, (no residual disease if known)</p><ul><li><p>for stage IB-II, missing residual disease is regarded as no residual disease</p></li>
</ul></li>
</ul></li>
<li><p>advanced:</p><ul><li><p>stage III-IVA, (with residual disease if known)</p></li>
</ul></li>
<li><p>metastatic:</p><ul><li><p>stage IVB</p></li>
</ul></li>
</ul></div>
    <div id="note">
    <h2>Note</h2>
    <p>Assignment starts from the low group first.</p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Concin N, Matias-Guiu X, Vergote I, et al ESGO/ESTRO/ESP
guidelines for the management of patients with endometrial
carcinoma. International Journal of Gynecologic Cancer Published Online
First: 18 December 2020. doi: 10.1136/ijgc-2020-002230</p>
    </div>
    <div id="author">
    <h2>Author</h2>
    <p>Derek Chiu</p>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span class="co"># without molecular classification</span></span>
<span class="r-in"><span class="va">esmo2020_wo_eclass</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/with.html" class="external-link">with</a></span><span class="op">(</span><span class="va">emdb</span>, <span class="fu">assign_esmo2020</span><span class="op">(</span><span class="va">stage_full</span>, <span class="va">grade_rev</span>,</span>
<span class="r-in"><span class="va">hist_rev_gr</span>, <span class="va">myo</span>, <span class="va">lvi</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/base/table.html" class="external-link">table</a></span><span class="op">(</span><span class="va">esmo2020_wo_eclass</span><span class="op">)</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> esmo2020_wo_eclass</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                51               100               130               285 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>          advanced        metastatic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                17                 6 </span>
<span class="r-in"></span>
<span class="r-in"><span class="co"># with molecular classification</span></span>
<span class="r-in"><span class="va">eclass</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/with.html" class="external-link">with</a></span><span class="op">(</span><span class="va">emdb</span>, <span class="fu"><a href="assign_promise2015.html">assign_promise2015</a></span><span class="op">(</span><span class="va">mmr_ihc_2</span>, <span class="va">pole_mut</span>, <span class="va">p53</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-in"><span class="va">esmo2020_w_eclass</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/with.html" class="external-link">with</a></span><span class="op">(</span><span class="va">emdb</span>, <span class="fu">assign_esmo2020</span><span class="op">(</span><span class="va">stage_full</span>, <span class="va">grade_rev</span>,</span>
<span class="r-in"><span class="va">hist_rev_gr</span>, <span class="va">myo</span>, <span class="va">lvi</span>, <span class="va">eclass</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/base/table.html" class="external-link">table</a></span><span class="op">(</span><span class="va">esmo2020_w_eclass</span><span class="op">)</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> esmo2020_w_eclass</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                75                53                89               265 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>          advanced        metastatic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                38                 6 </span>
<span class="r-in"></span>
<span class="r-in"><span class="co"># with molecular classification and residual disease</span></span>
<span class="r-in"><span class="va">esmo2020_w_eclass_res</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/with.html" class="external-link">with</a></span><span class="op">(</span><span class="va">emdb</span>, <span class="fu">assign_esmo2020</span><span class="op">(</span><span class="va">stage_full</span>, <span class="va">grade_rev</span>,</span>
<span class="r-in"><span class="va">hist_rev_gr</span>, <span class="va">myo</span>, <span class="va">lvi</span>, <span class="va">eclass</span>, <span class="va">residual</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/base/table.html" class="external-link">table</a></span><span class="op">(</span><span class="va">esmo2020_w_eclass_res</span><span class="op">)</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> esmo2020_w_eclass_res</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>               low      intermediate high-intermediate              high </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                70                53                89               239 </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>          advanced        metastatic </span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                32                 6 </span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Derek Chiu, Samuel Leung.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.3.</p>
</div>

      </footer></div>

  


  

  </body></html>

